Aatke M. Van Der Maas
Ubbergen, GE, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
Low value of routine serological screening for hepatitis B in patients with rheumatoid arthritis starting rituximab therapy in a nonendemic region.
Journal: EULAR rheumatology open
Published: June 29, 2026
Subcutaneous versus intravenous ultra-low dose rituximab in rheumatoid arthritis: a randomised controlled PK-PD non-inferiority trial.
Journal: Rheumatology (Oxford, England)
Published: February 03, 2026
Measurement properties of the Polymyalgia Rheumatica Activity Score (PMR-AS): reliability, measurement error and discriminative validity.
Journal: Rheumatology (Oxford, England)
Published: November 28, 2025
Glucocorticoid tapering strategies in polymyalgia rheumatica: a systematic literature review.
Journal: Rheumatology (Oxford, England)
Published: October 03, 2025
Patient experiences of PMR: a qualitative narrative literature review.
Journal: Rheumatology advances in practice
Published: August 11, 2025
Results of a 1-year randomised double-blind placebo-controlled trial with methotrexate 25 mg/week in recently diagnosed polymyalgia rheumatica.
Journal: Annals of the rheumatic diseases
Published: July 22, 2025
Deep learning predicts the effect of neoadjuvant chemotherapy for patients with triple negative breast cancer.
Journal: Journal of pathology informatics
Published: July 14, 2024
Definitions of and instruments for disease activity, remission and relapse in polymyalgia rheumatica: a systematic literature review.
Journal: Rheumatology (Oxford, England)
Published: May 20, 2024
Effect of using the Simple Erosion Narrowing Score or Sharp/van der Heijde score on the power of rheumatoid arthritis clinical trials to detect differences in radiographic progression.
Journal: Rheumatology (Oxford, England)
Published: November 06, 2023
Disease activity-guided dose optimization including discontinuation of TNF inhibitors in rheumatoid arthritis is effective for up to 10 years: an observational follow-up of the DRESS study.
Journal: Rheumatology (Oxford, England)
Published: November 01, 2023
Long-term clinical and radiological effectiveness and safety of ultralow doses of rituximab in rheumatoid arthritis: observational extension of the REDO trial.
Journal: RMD open
Published: August 30, 2023
Last Updated: 09/26/2026